Category: Pharmaceuticals
Pharmaceuticals market research reports by DelveInsight
-
Nucleotide Analog Reverse Transcriptase Inhibitor (NtRTI)s - Pipeline Insight, 2025
“Nucleotide Analog Reverse Transcriptase Inhibitor (NtRTI)s - Pipeline Insight, 2025” report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across Nucleotide Analog Reverse Transcriptase Inhibitor (NtRTI)s development. The ... Read More
-
Selective COX-2 Inhibitor - Pipeline Insight, 2025
“Selective COX-2 Inhibitor - Pipeline Insight, 2025” report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across Selective COX-2 Inhibitor development. The report provides detailed coverage of the pipeline landscape for t ... Read More
-
Semicarbazide Sensitive Amine Oxidase (SSAO) Inhibitor - Pipeline Insight, 2025
“Semicarbazide Sensitive Amine Oxidase (SSAO) Inhibitor - Pipeline Insight, 2025” report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across Semicarbazide Sensitive Amine Oxidase (SSAO) Inhibitor development. The report ... Read More
-
AXL Inhibitors - Pipeline Insight, 2025
DelveInsight’s, “AXL Inhibitors - Pipeline Insight, 2025” report provides comprehensive insights about 16+ companies and 20+ pipeline drugs in AXL Inhibitors pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics ... Read More
-
Chronic inflammatory demyelinating polyneuropathy (CIDP)- Pipeline Insight, 2025
DelveInsight’s, “Chronic inflammatory demyelinating polyneuropathy (CIDP)- Pipeline Insight, 2025” report provides comprehensive insights about 2+ companies and 4+ pipeline drugs in Chronic inflammatory demyelinating polyneuropathy (CIDP)pipeline landscape. It covers the pipeline drug profiles, incl ... Read More
-
Postmenopausal Osteoporosis - Pipeline Insight, 2025
DelveInsight’s, “Postmenopausal Osteoporosis - Pipeline Insight, 2025” report provides comprehensive insights about 8+ companies and 10+ pipeline drugs in Postmenopausal Osteoporosis pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also ... Read More
-
Guillain-Barré Syndrome (GBS) - Pipeline Insight, 2025
DelveInsight’s, “Guillain-Barré Syndrome (GBS) - Pipeline Insight, 2025” report provides comprehensive insights about 2+ companies and 3+ pipeline drugs in Guillain-Barré Syndrome (GBS) pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It al ... Read More
-
Glioma - Pipeline Insight, 2025
DelveInsight’s, “Glioma - Pipeline Insight, 2025” report provides comprehensive insights about 180+ companies and 200+ pipeline drugs in Glioma pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by ... Read More
-
Refractory Metastatic Melanoma - Pipeline Insight, 2025
DelveInsight’s, “Refractory Metastatic Melanoma - Pipeline Insight, 2025” report provides comprehensive insights about 4+ companies and 4+ pipeline drugs in Refractory Metastatic Melanoma pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It ... Read More
-
TCR Therapy- Pipeline Insight, 2025
DelveInsight’s, “TCR Therapy- Pipeline Insight, 2025” report provides comprehensive insights about 80+ companies and 100+ pipeline drugs in TCR Therapy pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessm ... Read More
-
Endothelin Receptor Antagonist - Pipeline Insight, 2025
DelveInsight’s, “Endothelin Receptor Antagonist - Pipeline Insight, 2025” report provides comprehensive insights about 10+ companies and 15+ pipeline drugs in Endothelin Receptor Antagonist pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. ... Read More
-
Molecular Glues - Competitive landscape, 2025
DelveInsight’s, “Molecular Glues - Competitive landscape, 2025,” report provides comprehensive insights about 50+ companies and 65+ drugs in Molecular Glues Competitive landscape. It covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further hi ... Read More
-
AXL Inhibitors - Pipeline Insight, 2025
DelveInsight’s, “AXL Inhibitors - Pipeline Insight, 2025” report provides comprehensive insights about 16+ companies and 20+ pipeline drugs in AXL Inhibitors pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics ... Read More
-
Comprehensive Analysis of PCOS: Epidemiology , Patient Journey, Market Trends, Unmet Needs, and Glycemic Management
-
Interventional Neuroradiology - Market Insights, Competitive Landscape, and Market Forecast - 2032
Interventional Neuroradiology Market by Device (Micro guidewires, Microcatheters, Flow Diversion Stents, Embolization Coils, Neurovascular Embolization Devices, and Others), Disease (Cerebral Aneurysms, Intra-cranial Tumors, Acute Ischemic Strokes, and Other Diseases), End-Users (Hospitals, Ambulato ... Read More
-
Cataract Surgery Devices - Market Insights, Competitive Landscape, and Market Forecast - 2030
Cataract Surgery Devices - Market Insights, Competitive Landscape, and Market Forecast - 2030 Cataract Surgery Devices Market by Product Type (Phacoemulsification Systems, Femtosecond Lasers, Intraocular Lenses, Ophthalmic Viscosurgical Devices, and Others), End-User (Hospitals and Specialty Clinics ... Read More
-
EGFR Non-Small Cell Lung Cancer (EGFR + NSCLC) - Pipeline Insight, 2024
EGFR Non-Small Cell Lung Cancer (EGFR + NSCLC) - Pipeline Insight, 2024 DelveInsight’s, “EGFR Non-Small Cell Lung Cancer (EGFR + NSCLC) - Pipeline Insight, 2024” report provides comprehensive insights about 40+ companies and 50+ pipeline drugs in EGFR Non-Small Cell Lung Cancer (EGFR + NSCLC) pipeli ... Read More
-
Alopecia - Pipeline Insight, 2024
Alopecia - Pipeline Insight, 2024 DelveInsight’s, “Alopecia - Pipeline Insight, 2024” report provides comprehensive insights about 18+ companies and 20+ pipeline drugs in Alopecia pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also cov ... Read More
-
Epidermolysis Bullosa - Pipeline Insight, 2024
Epidermolysis Bullosa - Pipeline Insight, 2024 DelveInsight’s, “Epidermolysis Bullosa - Pipeline Insight, 2024” report provides comprehensive insights about 20+ companies and 21+ pipeline drugs in Epidermolysis Bullosa pipeline landscape. It covers the pipeline drug profiles, including clinical and ... Read More
-
Pulmonary Fibrosis- Pipeline Insight, 2024
Pulmonary Fibrosis- Pipeline Insight, 2024 DelveInsight’s, “Pulmonary Fibrosis- Pipeline Insight, 2024” report provides comprehensive insights about 70+ companies and 75+ pipeline drugs in Pulmonary Fibrosis pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical ... Read More
-
Peanut Allergy - Pipeline Insight, 2024
Peanut Allergy - Pipeline Insight, 2024 DelveInsight’s, “Peanut Allergy - Pipeline Insight, 2024,” report provides comprehensive insights about 12+ companies and 15+ pipeline drugs in Peanut Allergy pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage pr ... Read More
-
Rett Syndrome - Pipeline Insight, 2024
Rett Syndrome - Pipeline Insight, 2024 DelveInsight’s, “Rett Syndrome - Pipeline Insight, 2024” report provides comprehensive insights about 20+ companies and 20+ pipeline drugs in Rett Syndrome pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage produc ... Read More
-
Helicobacter Pylori Infection - Pipeline Insight, 2024
Helicobacter Pylori Infection - Pipeline Insight, 2024 DelveInsight’s, “Helicobacter Pylori Infection - Pipeline Insight, 2024” report provides comprehensive insights about 5+ companies and 5+ pipeline drugs in Helicobacter Pylori Infection pipeline landscape. It covers the pipeline drug profiles, ... Read More
-
PD-1 and PD-L1 Inhibitors - Competitive landscape, 2024
PD-1 and PD-L1 Inhibitors - Competitive landscape, 2024 DelveInsight’s, “PD-1 and PD-L1 Inhibitors - Competitive landscape, 2024,” report provides comprehensive insights about 180+ companies and 200+ drugs in PD-1 and PD-L1 Inhibitors Competitive landscape. It covers the therapeutics assessment by ... Read More
-
Pancreatic Cancer - Competitive Landscape, 2024
Pancreatic Cancer - Competitive Landscape, 2024 DelveInsight’s, “Pancreatic Cancer - Competitive landscape, 2024,” report provides comprehensive insights about 180+ companies and 190+ drugs in Pancreatic Cancer Competitive landscape. It covers the therapeutics assessment by product type, stage, rou ... Read More
Research Assistance
